Market Access Understanding the evolution of container closure integrity t... At different stages of the drug lifecycle, the minimum provision for parenteral products is a safety barrier against potential contaminants.
Partner Content Partner Content Industry Gathers Next Week at Pharmaceutical Microbiology Ea... Last chance to register
Partner Content Partner Content The Power of Partnerships: Meeting Pharmaceutical Logistic E... Partnerships in the Supply Chain
Events Partner Content SMi's 12th annual Cold Chain Distribution Conference and Exh... This year's event will continue to lead.
News Lilly grabs first-ever FDA nod for a sleep apnoea drug Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea, which affects millions in the US.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.